Alpha 2.0
Login Register
» Authors » Seung-Phil Shin

Seung-Phil Shin

Explore the profile of Seung-Phil Shin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 39
Followers 0
Related Specialty
Oncology
Top 10 Co-Authors
Sang-Jin Lee
Yuh-Seog Jung
Enkhjin Saruuldalai
Hyeon-Gu Kang
In-Hoo Kim
Hwi-Ho Lee
A-Ra Goh
Yeon-Su Lee
Jong-Kwang Kim
Jiyoung Joan Jang
Published In
Mol Ther Oncolytics
Cancer Lett
Oncotarget
Vaccines (Basel)
Cancers (Basel)
Affiliations
Soon will be listed here.
Recent Articles
1.
Adenovirus expressing nc886, an anti-interferon and anti-apoptotic non-coding RNA, is an improved gene delivery vector
Saruuldalai E, Lee H, Lee Y, Hong E, Ro S, Kim Y, et al.
Mol Ther Nucleic Acids . 2024 Aug; 35(3):102270. PMID: 39171141
Recombinant adenovirus (rAdV) vector is the most promising vehicle to deliver an exogenous gene into target cells and is preferred for gene therapy. Exogenous gene expression from rAdV is often...
2.
The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates
Shin S, Shin K, Lee J, Jung I, Koo J, Lee S, et al.
Vaccines (Basel) . 2022 May; 10(5). PMID: 35632468
Several COVID-19 platforms have been licensed across the world thus far, but vaccine platform research that can lead to effective antigen delivery is still ongoing. Here, we constructed AdCLD-CoV19 that...
3.
A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus
Saruuldalai E, Park J, Kang D, Shin S, Im W, Lee H, et al.
Mol Ther Oncolytics . 2022 Mar; 24:683-694. PMID: 35284627
Elucidation of the interplay between viruses and host cells is crucial for taming viruses to benefit human health. Cancer therapy using adenovirus, called oncolytic virotherapy, is a promising treatment option...
4.
Local adenoviral delivery of soluble CD200R-Ig enhances antitumor immunity by inhibiting CD200-β-catenin-driven M2 macrophage
Shin S, Goh A, Ju J, Kang H, Kim S, Kim J, et al.
Mol Ther Oncolytics . 2021 Oct; 23:138-150. PMID: 34703882
CD200 is known as an immune checkpoint molecule that inhibits innate immune cell activation. Using a head and neck squamous cell carcinoma (HNSCC) model, we sought to determine whether localized...
5.
CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation
Shin S, Goh A, Kang H, Kim S, Kim J, Kim K, et al.
Cancers (Basel) . 2019 Oct; 11(10). PMID: 31627350
The membrane glycoprotein CD200 binds to its receptor CD200R1 and induces tolerance, mainly in cells of the myeloid lineage; however, information regarding its role in solid tumors is limited. Here,...
6.
The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression
Seo H, Shin S, Jung N, Kwon W, Jeong K, Lee S
Oncotarget . 2017 Sep; 8(31):50500-50509. PMID: 28881578
To properly evaluate the biological effects of immunotherapy, it is critical to utilize a model of cancer in immune-competent mice. Currently, MBT-2 is the most common murine bladder cancer cell...
7.
Ad5/35E1aPSESE4: A novel approach to marking circulating prostate tumor cells with a replication competent adenovirus controlled by PSA/PSMA transcription regulatory elements
Hwang J, Joung J, Shin S, Choi M, Kim J, Kim Y, et al.
Cancer Lett . 2016 Jan; 372(1):57-64. PMID: 26723876
Circulating tumor cells serve as useful biomarkers with which to identify disease status associated with survival, metastasis and drug sensitivity. Here, we established a novel application for detecting PSA/PSMA-positive prostate...